Author

Rajesvaran Ramalingam

Acuitas Therapeutics (Canada)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:multiome· 1 Research Focus:perturbation response prediction· 1 Organism:rat· 1

Frequent Co-Authors

Amie AlbertusiD· 1 shared Angela R. CorriganiD· 1 shared Drew WeissmaniD· 1 shared E. John WherryiD· 1 shared Edward F. KreideriD· 1 shared Houping NiiD· 1 shared Jacob T. HamiltoniD· 1 shared Jayme M.L. NordiniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Amie AlbertusORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

In vivo reprogramming of cytotoxic effector CD8+ T cells via fractalkine-conjugated mRNA-LNP

Angela R. Corrigan, Shin Foong Ngiow, Maura Statzu, Amie Albertus, María Betina Pampena, Jayme M.L. Nordin, Stephen D. Carro, Justin L. Harper, Rachelle L. Stammen, Jennifer Wood, Houping Ni, Justin Su, Marziyeh Hajialyani, Vladimir V. Shuvaev, Víctor Alcalde, , Michael R. Betts

This study shows fractalkine-conjugated mRNA-LNP can target and modify CD8+ T cells in vivo, enabling transient expression of proteins like IL-2 and CD62L.

Science Immunology · May 29, 2026Peer-reviewedImmunology